Point-of-Care (POC) Coagulation Testing Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Point-of-Care (POC) Coagulation Testing Market?
The point-of-care (POC) coagulation testing market is predicted to expand in response to the growing prevalence of cardiovascular diseases. These diseases, commonly known as CVDs, encompass heart and blood vessel disorders, including coronary heart disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation testing plays a significant role in treating CVDs by providing real-time data on coagulation status, allowing for immediate decisions on coagulation interventions and minimizing post-cardiac surgery bleeding risks. The World Heart Federation, a Swiss non-governmental organization, reported in October 2022 that mortality from cardiovascular disease is expected to increase. The report projects that deaths from CVDs are anticipated to climb from approximately 18.9 million in 2020 to over 22.2 million by 2030, extending to 32.3 million by 2050. Thus, the increasing occurrence of cardiovascular diseases is fueling the growth of the point-of-care (POC) coagulation testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
#What is the Growth Potential of the Point-of-Care (POC) Coagulation Testing Market, and How Will It Perform by 2034?
Over the recent years, the point-of-care (POC) coagulation testing market has expanded significantly. The market, which stands at $1.18 billion in 2024, is projected to rise to $1.25 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.8%. The historical growth trajectory is linked to factors like higher patient demand, increased adoption of POC testing, utmost faith in coagulation status on pt test, automation, integration into electronic health records (EHRs), and escalating occurrences of cardiovascular diseases and blood-related disorders.
In the coming years, the point-of-care (POC) coagulation testing market is projected to experience robust growth, with its value anticipated to reach $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. This growth during the forecast period can be credited to the broader applications within the healthcare sector, increased usage in home-based care, greater occurrences of chronic blood diseases, robust patient demand for swift and precise testing, and a rise in POC testing. Noteworthy trends for the forecast period comprise technological evolution, significant demand in developed nations, broader healthcare applications, the impact of COVID-19, and the expanding prevalence of multiplexing POC diagnostics.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913
What New Market Trends Are Reshaping thePoint-of-Care (POC) Coagulation Testing Market and Its Opportunities?
Prominent firms in the point-of-care (POC) coagulation testing market are turning to strategic partnerships as a way to strengthen their position in the market. These partnerships are formal agreements among two or more entities, working in unity for achieving predefined beneficial outcomes. For example, in January 2023, Jana care, a company based in the US, which is developing biomarker assays for its unique digital health platform, entered into a partnership with Roche Diagnostics, a Switzerland-based company renowned for developing diagnostic tests, instruments, and digital healthcare solutions. The aim of this partnership is to create and distribute a point-of-care blood testing platform to monitor chronic kidney disease and heart failure. This revolutionary platform will allow patients to run blood tests from home, ensuring the results can be analysed remotely by medical professionals.
Who Are the Leading Market Players Fueling Growth in the Point-of-Care (POC) Coagulation Testing Market Trend?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Order Your Report Now For A Swift Delivery:
How is the Global Point-of-Care (POC) Coagulation Testing Market Segemented?
The point-of-care (POC) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
Which Geographics are Influencing the Growth of the Point-of-Care (POC) Coagulation Testing Market?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2025, By The Business Research Company:
Lancing Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
Implantable Drug Delivery Devices Global Market Report 2024
Interventional Neurology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
